Search All Tech Briefings


Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available.  Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 1184 Results

Title
Intervention Indication Therapeutic Area Year Actions
Lenalidomide (Revlimid) + rituximab for relapsed/refractory follicular lymphoma and marginal zone lymphoma Lenalidomide (Revlimid) , Rituximab (MabThera; Rituxan; RG 105) Follicular lymphoma , Marginal zone lymphoma (MZL) Haematological Cancer and Lymphomas 2017 View  |  Download
Lenadogene Nolparvovec (GS-010) for Vision Loss from Leber's Hereditary Optic Neuropathy Due to Mutation of the ND4 Gene Lenadogene nolparvovec (Lumevoq; GS-010) Leber's hereditary optic neuropathy (LHON) Genetic Disorders , Ophthalmology 2017 View  |  Download
Lenacapavir with optimised background regimen for treating multidrug resistant human immunodeficiency virus (HIV)-1 infection in people aged 12 years and older Lenacapavir (GS-6207) HIV-1 infection Infectious Disease 2022 View  |  Download
Lenabasum for Diffuse Cutaneous Systemic Sclerosis Lenabasum (JBT-101) Systemic sclerosis Dermatology , Respiratory System 2018 View  |  Download
Lecanemab for treating early Alzheimer's disease Lecanemab (BAN2401) Alzheimer's disease Neurology 2021 View  |  Download
Lebrikizumab for moderate to severe atopic dermatitis Lebrikizumab (TNX-650; LY3650150) Atopic dermatitis Dermatology 2021 View  |  Download
Lazertinib with amivantamab and platinum-based chemotherapy for EGFR-mutated locally advanced or metastatic non-small-cell lung cancer after osimertinib failure Amivantamab (JNJ-6372; JNJ-61186372) , Lazertinib , Platinum-based chemotherapy Non-small-cell lung cancer (NSCLC) Lung and Respiratory Cancer 2022 View  |  Download
Lasmiditan for acute treatment of migraine Lasmiditan (COL-144; LY573144) Migraine Neurology 2020 View  |  Download
Larotrectinib (LOXO-101) for advanced solid cancers [with an NTRK1, NTRK2, or NTRK3 gene fusion] Larotrectinib (LOXO-101; Viktravi; larotrectinib sulfate) Solid tumours Haematological Cancer and Lymphomas , Oncology 2017 View  |  Download
Lanadelumab for prevention of attacks in adults and adolescents with Type I and Type II hereditary angioedema Lanadelumab (SHP643; TAK-743; Takhzyro) Hereditary angioedema (HAE) Genetic Disorders , Immunology 2017 View  |  Download
1 2 63 64 65 66 67 118 119
Medicines
Medicine Industry's Gateway to NICE
Support for Industry
Outputs & Publications